These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10829930)

  • 41. Congenital adrenal hyperplasia and early newborn screening: 17 alpha-hydroxyprogesterone (17 alpha-OHP) during the first days of life.
    Gruñeiro de Papendieck L; Prieto L; Chiesa A; Bengolea S; Bergadá C
    J Med Screen; 1998; 5(1):24-6. PubMed ID: 9580500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Do we need congenital adrenal hyperplasia screening for premature infants?].
    Huet F; Godefroy A; Cheillan D; Somma C; Roussey M
    Arch Pediatr; 2014 Feb; 21(2):233-6. PubMed ID: 24361036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of Serum 17α-Hydroxyprogesterone in Infants by Radioimmunoassay.
    Muñoz LN; Ochetti M; Perez G; Sobrero GM; Silvano LK; Martin SE; Testa GM; Miras MB
    Pediatr Endocrinol Rev; 2015 Jun; 12(4):366-72. PubMed ID: 26182481
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neonatal levels of 17-hydroxyprogesterone--early diagnosis of adrenogenital syndrome].
    Sulcová J; Tichá H; Wiererová O
    Cesk Pediatr; 1989 Dec; 44(12):716-8. PubMed ID: 2636556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neonatal screening for congenital adrenal hyperplasia.
    Cacciari E; Balsamo A; Cassio A; Piazzi S; Bernardi F; Salardi S; Cicognani A; Pirazzoli P; Zappulla F; Capelli M
    Arch Dis Child; 1983 Oct; 58(10):803-6. PubMed ID: 6639129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G; García de la Rosa I; González Reyes EC; Rubio Torres A; Quintana Guerra JM; Hernández Marín M; Pérez Mora PL; Feal Carballo S; Lafita Delfino Y; Pupo Infante M; Castells Martínez EM; Rosabal Poloshkov A; Hernández Pérez L
    Clin Chim Acta; 2018 Oct; 485():311-315. PubMed ID: 30006291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Newborn Screening and Diagnosis of Infants with Congenital Adrenal Hyperplasia.
    Vats P; Dabas A; Jain V; Seth A; Yadav S; Kabra M; Gupta N; Singh P; Sharma R; Kumar R; Polipalli SK; Batra P; Thelma BK; Kapoor S
    Indian Pediatr; 2020 Jan; 57(1):49-55. PubMed ID: 31937698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens.
    Thompson R; Seargeant L; Winter JS
    J Pediatr; 1989 Mar; 114(3):400-4. PubMed ID: 2784166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving neonatal screening for congenital adrenal hyperplasia.
    Speiser PW
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3685-6. PubMed ID: 15292288
    [No Abstract]   [Full Text] [Related]  

  • 50. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
    Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
    J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
    Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible andrologic markers in elevated neonatal 17-hydroxyprogesterone.
    Cavarzere P; Vincenzi M; Gaudino R; Franceschi R; Perlini S; Camilot M; Teofoli F; Antoniazzi F; Tatò L
    Fertil Steril; 2010 Nov; 94(6):2350-2. PubMed ID: 20537623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
    J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of gestational age and birth weight on false-positive newborn-screening rates.
    Slaughter JL; Meinzen-Derr J; Rose SR; Leslie ND; Chandrasekar R; Linard SM; Akinbi HT
    Pediatrics; 2010 Nov; 126(5):910-6. PubMed ID: 20974783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F; Török D; Kovács J; Möslinger D; Baumgartner-Parzer SM; Sólyom J; Pribilincová Z; Battelino T; Lebl J; Frisch H; Waldhauser F;
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of androstenedione levels by an in-house radioimmunoassay.
    Lo MS; Ng ML; Wu LL; Khalid BA
    Malays J Pathol; 1996 Jun; 18(1):53-8. PubMed ID: 10879225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of a steroid profile in heel prick blood using LC-MS/MS.
    Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
    Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
    Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.